- Continue Shopping
- Your Cart is Empty
Hexoskin to Present at the HITLAB Innovation Summit 2025
Hexoskin's CEO Pierre-Alexandre Fournier is going to present our latest work in AI and digital biomarker development for clinical trials at the HITLAB Innovators Summit 2025 this December 2-4 in New York City.
Hexoskin Medical System Receives FDA 510(k) Clearance for Long-Term ECG and Respiratory Monitoring
The Hexoskin Medical System (HMS) is now an FDA-cleared, medical-grade smart shirt for continuous, long-term ECG, respiratory, and activity monitoring. It’s a premier remote monitoring solution for cardiopulmonary chronic conditions (COPD, Afib) and complements the validated AI-based digital biomarker platform for clinical trials in cardiovascular, respiratory, and rare diseases.
View full article →Hexoskin @ HLTH 2025
Hexoskin will be presenting its latest products and clinical advancements at HLTH USA 2025 next week in Las Vegas.
We'll take the opportunity to meet with our clients and partners who use the Hexoskin software platform and wearables to advance our knowledge of human physiology.
We'll also present our new Hexoskin OneView platform for research and our digital biomarker pipeline in cardiology, respiratory diseases, nervous system disorders, and rare diseases.
Contact us to book a meeting: contact@hexoskin.com
From Data Collection to Reporting: See How Hexoskin Streamlines Your Entire Physiological Monitoring Workflow
Join Our Free Technical Deep Dive on September 17, 2025
Effective physiological monitoring goes far beyond simple data collection. The real challenge for researchers, data scientists, and R&D professionals is managing the entire workflow, from organizing participant data to reporting meaningful insights. Juggling disparate tools for each step is inefficient and can compromise your project's integrity.
The Hexoskin platform is designed to solve this challenge by providing a single, seamless solution for your entire process. Join our exclusive webinar on September 17, 2025, at 11:00 am EDT to see how you can streamline every stage of your work.
What You Will Learn in This Deep Dive Session:
This 60-minute session will provide a live demonstration of the comprehensive tools built into the Hexoskin platform. We will cover:
- Data Collection: How to capture continuous, high-resolution physiological data with our smart clothing, designed for minimal participant burden.
- Data Organization: Best practices for using our integrated cohort management and data synchronization tools to keep your projects organized and secure.
- Data Analysis: A look at the platform’s built-in visualization and analysis features that help you get to insights faster.
- Data Reporting: How to use streamlined export options and reporting tools to prepare your findings for publication or presentation.
- Expert Guidance: You'll have the chance to ask our technical team your specific questions during a live Q&A session.
Who Should Attend?
This event is perfect for researchers, developers, AI teams, data scientists, and R&D professionals. It is also ideal for any organization currently implementing or considering physiological or remote monitoring solutions.
Don't miss this opportunity to master your workflow. Register today for our free technical deep dive!
Hexoskin Unveils Breakthrough Cough Detection AI Algorithm in Computers in Biology and Medicine Journal
Hexoskin’s Artificial Intelligence team has published this week a breakthrough study in Computers in Biology and Medicine, introducing a novel algorithm for automatic cough detection in real‑world settings. Unlike traditional methods, our approach preserves patients’ speech privacy and excels even in noisy environments.
This novel AI detection model was developed using physiological recordings from Hexoskin smart garments, a Digital Health Technology (DHT) wearable cardiac, respiratory, and activity sensor. The model delivers best‑in‑class performance with an area under the ROC curve (AUC) of 95.2 %, sensitivity of 98.5 %, and specificity of 91.9 %. This level of accuracy meets the stringent requirements for cough clinical trial endpoints.
Passive and objective cough measurement devices like Hexoskin smart garments can report outcomes for patients living with respiratory conditions such as asthma and COPD. Because Hexoskin Smart Clothing can be used in clinical trials at home, enabling remote patient monitoring, patients can be monitored for their respiratory condition during daily activities and sleep. AI-based cough detection can provide a detailed analysis of the frequency of cough events, combined with other clinical trial endpoints.
“Detecting coughs accurately without capturing speech content is essential for both patient privacy and clinical utility,” said Dr. Philippe Dixon, lead author of the study and assistant professor at McGill University. “Our model’s robustness to ambient noise makes it an ideal tool for home‑based monitoring and telemedicine applications, key aspects of remote respiratory monitoring.”
This announcement represents the latest advance in Hexoskin’s expanding clinical AI portfolio. In parallel with ongoing clinical trials, Hexoskin leverages the world’s largest physiological database—accumulated through years of wearable sensor deployments—to accelerate the development of AI‑driven tools for patient monitoring and diagnostics.
Here's an excerpt from the paper's abstract:
Coughing behavior is associated with conditions such as sleep apnea, asthma, and chronic obstructive pulmonary disorder (COPD) and can severely affect quality of life in those affected. In this context, coughing quantification is often important, but routinely performed via questionnaires. This approach is dependent on patient compliance or recall, which may affect validity and be especially difficult for nocturnal coughs. Manual review of audio recordings is potentially more accurate, but raises adherence and privacy concerns due to the collection and review of sensitive audio-data by a human annotator. Today, machine learning approaches are increasingly used to quantify coughs; however, algorithms often rely on microphone recordings, resulting in the same privacy issues, especially if data are sent to a remote server for analysis.
Hexoskin's open platform is used by hundreds of researchers for data collection for new digital biomarkers and AI development. Hexoskin is also working with foundations, pharmaceuticals, and biotechnology to speed the clinical development of respiratory diseases and other cardiac, neurological, and rare diseases, developing primary and secondary endpoints for clinical development. We also collaborate on digital biomarkers for patient monitoring and find new cures.
Contact our team today to collaborate on the future of clinical development and AI in healthcare.
Health Sensors & AI for the Pharmaceutical Industry
Backed by over 250 scientific and peer-reviewed publications, and validated through several clinical trials, research, and case studies, explore Hexoskin’s proven end-to-end AI-driven solutions for pharmaceutical companies. With real-time monitoring of more than 25 data channels and 75 key metrics, learn more about all the concrete benefits of our Health Sensors & Connected Platform.
Hexoskin’s expertise in supporting pharmaceutical research
Since 2006, Hexoskin has been dedicated to democratizing access to high-precision health data collected through wearable smart clothing sensors. We are proud to develop reliable, tried-and-tested healthcare technologies that are now used by many universities, research centers, hospitals, and pharmaceutical companies across the world. Recognized for our excellent support, and always responsive to our clients’ needs, our all-in-one solution provides a complete tool for maximizing the results of any pharmaceutical research project.
Here are some of our pharma clients and partners who have chosen to work with us :
Real-world evidence data and reporting of digital biomarkers
With accurate long-term remote patient monitoring through Hexoskin Health Sensors & AI and a cutting-edge connected health platform, our innovative solution is perfect for the management and reporting of all key metrics and data collected when performing pharmaceutical research and decentralized clinical trials (DCT). Using washable, breathable, quick-dry, and comfortable tech clothing, Hexoskin Smart Clothing Monitor helps optimize patient’s satisfaction and adherence contributing positively to the outcome of research protocols, while collecting accurate, relevant, and efficient data.
-
Continuous high-resolution electrocardiography ;
-
Respiratory capacity measurements (tidal volume, respiratory rate, RRV, minute ventilation, etc.) ;
-
Activity, cardiac & pulmonary function collected simultaneously, 24/7, uninterrupted ;
-
Secure data synchronization and storage ;
-
Cost-effective biometric monitoring solution for pharmaceutical trials and research.
Interested in learning more about Hexoskin Health Sensors & AI for the pharmaceutical industry ? Contact our team now. We will gladly discuss the specific needs of your organization in order to provide you with the best results-oriented solution !
Health Sensors & AI for Academic Research
Achieve excellence in health tracking with Hexoskin connected platform & biometric smart garments. Trusted by researchers and professionals around the world, and used by many universities, research centers, medical centers, and much more, explore all the benefits our Health Sensors & AI may bring to your academic research.
Real-time monitoring for faster communication and reporting
With years of expertise in health data analytics, Hexoskin Connected Health Platform stands out as a safe, easy-to-use, and highly reliable online platform to collect high-resolution real-world key health metrics. Hexoskin sets new benchmarks by providing accurate long-term monitoring with real-time data, available day-and-night, 365 days a year.
Enrich your academic research projects by taking advantage of benefits such as :
- Successfully supported projects & deployments since 2006 ;
- Excellent value proposition for enrollment and retention of patients / participants ;
- Improved patient experience, using washable and comfortable smart clothing ;
- Continuous cardiac, respiratory, activity & sleep data and metrics, easily transmitted and collected ;
- Faster communication, planning & study management for academic research ;
- Data quality & clinical endpoints reporting and analysis ;
- Enhanced collaborative learning, consolidating all studies under one single roof.
All-in-one AI solution for clinical & academic research
Take advantage of advanced features for real-world evidence data and reporting of digital biomarkers. Backed by over 250 scientific publications, research, and clinical trials, Hexoskin health sensors & AI deliver proven innovation in connected health. Explore our cost-effective, all-in-one solution for streamlined data monitoring of digital biomarkers and expand your possibilities when achieving professional projects, research, and studies. Powered by data science, Hexoskin is your key partner, helping you to transform objective endpoints into evidence-based health solutions.
All these organizations have chosen to invest their trust in us. Join them by requesting your free demo. Contact our team now to discuss your needs. Be ready to experience the full potential of Hexoskin health sensors & AI for academic research!
How Health Sensors & AI are revolutionizing Clinical Research
As healthcare technology evolves, AI and health sensors are contributing to a new era in clinical research. Making trials more precise, efficient, and patient-friendly, AI-powered sensors now provide real-time data, offering researchers and clinicians a clearer picture of patient health.
AI and Health Sensors in Research: an essential reality
In addition to improving the accuracy and efficiency of clinical studies, health sensors and AI solutions help ensure better patient compliance, global satisfaction, and adherence to treatment. This biometric monitoring solution implies earlier detection of health problems and adverse effects, ensuring better-informed decisions.
It is not surprising to observe that AI technology and Digital Health Technologies (DHTs) are increasingly becoming an integral part of the medical research industry, benefiting both scientists and patients.
Key Benefits of Health Sensors in Clinical Trials
The ultimate objective beyond this technology? Optimizing the performance and efficiency of clinical development in every aspect. More concretely, here are the 5 key advantages of implementing health sensors & AI in clinical research.
1. Real-time, continuous data collection
Using comfortable garments for precise and continuous cardiac, respiratory, and activity monitoring, Hexoskin smart clothing provides researchers with high-frequency, real-time insights. Connected to a high-tech health platform, sensors and AI help improve the reliability of remote patient monitoring data.
- Cardiac monitoring (1-lead ECG, Heart Rate, HRV, Heart Rate Recovery, etc.);
- Respiratory monitoring for COPD / Asthma (breathing rate, BRV, tidal volume, cough, BPratio, etc.);
- Stress monitoring (heart rate, HRV, breathing rate, sleep latency, sleep percent, etc.);
- Activity monitoring (3-Axis accelerometry, cadence, step count, calories, activity level, and more).
2. Improved patient monitoring and safety
Health sensors and remote monitoring also play a crucial role in improving patient safety during clinical trials. This non-invasive technology continuously tracks vital signs and physiological data, providing real-time insights and reducing reliance on in-person periodic check-ups.
- Earlier detection of warning signs for adverse reactions;
- All essential data collected and analyzed in a single place;
- Quicker intervention when needed;
- Better patient outcomes.
Remote monitoring of key health metrics using tech clothing also contributes to reducing hospital visits, ensuring accurate, uninterrupted health data, while enhancing treatment precision and clinical trial results.
3. Better efficiency and cost reduction with DHTs
Health sensors & AI have the advantage of offering a great cost-effective DHT solution for continuous and meticulous health tracking during clinical research. Wearable technologies also contribute to optimize data collection, accelerate study timelines, enhance patient convenience through remote monitoring, and reduce operational costs.
4. Increased patient engagement and compliance
We know that patient comfort and full engagement are vital to the success of clinical trials. Remote biometric monitoring using AI & health sensors has the benefit of reducing patient burden, improving adherence and patient participation, especially for decentralized trials.
5. Comprehensive data analysis with proven, validated results
Backed by over 250 scientific publications and validated outcomes from clinical trials and case studies, the Hexoskin Connected Health Platform is recognized as an innovative, clinically validated solution for comprehensive data analysis. Plus, Hexoskin is also a powerful proven approach for long-term patient monitoring.
The Future of Clinical Research with Digital Health Technologies
The field of clinical research is currently undergoing a major transformation. Through artificial intelligence (AI), remote monitoring, smart clothing, and advanced health sensors, technologies are redefining how physiological data is collected and analyzed. The future of clinical research must therefore take into account the existence of health sensors and AI resources, in order to integrate them seamlessly for the well-being of patients and the advancement of scientific knowledge.
Hexoskin wins contract to bring Astroskin sensors to the Moon
Montréal, November 26th, 2024
The Canadian Space Agency (CSA) has announced that it has awarded a contract to Hexoskin (Carré Technologies Inc.), a company based in Montreal, to develop and adapt the Astroskin Bio-Monitor crew physiological monitoring system for Gateway, a space station that will orbit the Moon.
The first two elements of Gateway – the Power and Propulsion Element (PPE) and the Habitation and Logistics Outpost (HALO) – are set to launch together in 2027.
The Astroskin Bio-Monitor has been in operation on the International Space Station (ISS) since January 2019, when it was commissioned by Canadian astronaut David Saint-Jacques. It is currently used in four clinical trials in space focused on studying the cardiorespiratory system and the accelerated aging effect of microgravity on human physiology.
Astroskin wearable sensors are sent to space on a regular basis, with 20 space payloads delivered to ISS so far, and a first suborbital flight completed in November 2023 with American astronaut Kellie Gerardi on Virgin Galactic’s mission 5.
More than 20 astronauts have used Astroskin wearable sensors for clinical research in microgravity, including astronauts from the USA, Canada, Japan, UAE, and Italy. (Photo credits: CSA, ESA, NASA, JAXA, Axiom/Mark Pathy, UAE Space Agency)
Astroskin wearable health sensors are also used by a large number of medical researchers around the world to study a wide number of health conditions, from hypertension to sleep quality, in clinical trials, and for defense and aerospace applications.
About Hexoskin, Space Medicine, and Clinical Research
Hexoskin has been involved in space medicine since its first contract with CSA in 2011. The investment from CSA in space medicine research has been a major driver of growth in the early development of the company, during the development of the Hexoskin and Astroskin wearable sensor platforms. Hexoskin has supported hundreds of clinical research projects since, leading to over 250 peer-reviewed scientific publications, patents, and novel AI software for clinical applications, with a focus on cardiac and respiratory diseases. Hexoskin participated in the first cohort of the ASU/Mayo Clinic Medtech accelerator in 2019.
More info on the Gateway contract awarded to Hexoskin:
https://www.nasa.gov/mission/gateway/
More info on Astroskin:
https://www.hexoskin.com/astroskin
HITLAB September 2024 Symposium on September 26
Hexoskin's CEO Pierre-Alexandre Fournier will be speaking at the HITLAB Digital Health Symposium on Digital Health this September 26th. The event will be streamed online and is free to attend.
Along with speakers from Genentech, Pfizer, Merck, Samsung, and many other innovative companies in health technologies and life sciences, Fournier will discuss the current state of digital biomarkers, wearables, and articificial intelligence in medicine.
For more than 20 years, HITLAB (Healthcare Innovation & Technology Lab) has been at the forefront of digital health research. The Columbia University-based organization partners with innovative healthcare technologies and life sciences companies to improve global health delivery and healthcare worldwide. HITLAB uses rigorous research and evidence-based methods to identify the best digital health solutions for their partners.
